Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-09FDA Approved: SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market a generic sodium ferric gluconate complex in sucrose. T…
-
FDA approval · 2025-08-08FDA Approved: IRON SUCROSE — Original Application (International Medication Systems, Limited)
FDA approved a generic iron sucrose injection from International Medication Systems as an Original Application (ANDA 208977).
-
FDA approval · 2025-07-11FDA Approved: KERENDIA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Kerendia (finerenone) submitted by Bayer HealthCare Pharmaceuticals Inc. The action concerns…
-
EMA approval · 2025-07-11EMA Authorised: Epoetin Alfa Hexal (epoetin alfa) — Hexal AG
The EMA authorised Epoetin Alfa Hexal (epoetin alfa) from Hexal AG to treat anemia associated with chronic kidney disease and related condit…
-
EMA approval · 2025-07-11EMA Authorised: Binocrit (epoetin alfa) — Sandoz GmbH
EMA authorised Binocrit (epoetin alfa) by Sandoz GmbH for the treatment of anemia associated with chronic kidney disease, myelodysplastic sy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-07-11EMA Authorised: Abseamed (epoetin alfa) — Medice Arzneimittel Pütter GmbH Co. KG
EMA has authorised Abseamed, an epoetin alfa product by Medice, for treatment of anemia associated with chronic kidney disease and certain h…
-
FDA approval · 2025-05-08FDA Approved: FUROSEMIDE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for furosemide by Eugia US LLC under an ANDA, confirming approval of the supplement.
-
EMA approval · 2025-05-02EMA Authorised: NeoRecormon (epoetin beta) — Roche Registration GmbH
The EMA authorised NeoRecormon (epoetin beta) from Roche Registration GmbH for multiple indications, including chronic kidney disease–relate…
-
EMA approval · 2025-04-15EMA Authorised: Mircera (Methoxy polyethylene glycol-epoetin beta) — Roche Registration GmbH
Mircera (methoxy polyethylene glycol-epoetin beta) has been authorized by the EMA for the treatment of anemia, including in chronic kidney d…
-
FDA approval · 2025-04-03FDA Approved: BUMETANIDE — Original Application (First Nation Group, LLC)
FDA approves bumetanide under an Original Application filed by First Nation Group, LLC (ANDA219291).
-
FDA approval · 2025-03-13FDA Approved: LANTHANUM CARBONATE — Original Application (Ascend Laboratories, LLC)
FDA approved the Original Application for LANTHANUM CARBONATE as a generic product, manufactured by Ascend Laboratories, LLC.
-
FDA approval · 2025-03-10FDA Approved: SEVELAMER CARBONATE — Supplemental Application (DR. REDDY'S LABORATORIES LIMITED)
FDA approves a supplemental application for sevelamer carbonate filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2025-02-27FDA Approved: BUMETANIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for bumetanide, a loop diuretic used to treat edema due to congestive heart failur…
-
FDA approval · 2025-02-03FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for sevelamer hydrochloride (generic) by Zydus Pharmaceuticals USA Inc. for the treatment of hyperphos…
-
FDA approval · 2025-01-31FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Lanthanum carbonate from Cipla USA Inc., approving an update to the product's labeling for the g…
-
EMA approval · 2025-01-22EMA Authorised: Renagel (sevelamer) — Sanofi Winthrop Industrie
The EMA authorised Renagel (sevelamer) for hyperphosphatemia in patients with chronic kidney disease on dialysis, with Sanofi Winthrop Indus…
-
FDA approval · 2024-12-11FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lanthanum carbonate from Teva Pharmaceuticals USA, Inc. This action is a supplemental approval f…
-
FDA approval · 2024-10-24FDA Approved: SEVELAMER CARBONATE — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical's sevelamer carbonate through an original application as a phosphate binder to control serum phosphate in…
-
FDA approval · 2024-10-01FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
The FDA approved a supplemental application for furosemide from Phlow Corporation, authorizing an additional or revised approval for the diu…
-
FDA approval · 2024-08-29FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2024-08-29FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2024-08-01FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2024-07-01FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) submitted by Fresenius Medical Care Renal Therapies Grou…
-
FDA approval · 2024-06-04FDA Approved: RETACRIT — Supplemental Application (Vifor (International) Inc.)
The FDA approved a supplemental application for RETACRIT (epoetin alfa-epbx) submitted by Vifor (International) Inc.
-
FDA approval · 2024-05-09FDA Approved: SEVELAMER CARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved the original application for Sevelamer carbonate from Strides Pharma Science Limited. The product is a phosphate binder used to…